by VH102021 | Sep 13, 2022 | News&events
VisMederi Pharma Srl and its new line of supplements have been officially presented this evening at the Volte di Vicobello location in Siena, in front of a large audience made up of local pharmacists and doctors operating on the territory. “I am really proud...
by VH102021 | Jun 1, 2022 | News&events
This morning at the Auditorium of the Toscana Life Sciences Foundation, the company ETHS Srl, part of the VisMederi Group, received a visit from the students of Kent State University (USA) taking part in the “Florence Health Institute” (FHI) Program,...
by VH102021 | Mar 9, 2022 | News&events
VisMederi Srl took part into research on antibody and cellular response induced by mRna vaccine against Covid-19. This trial involved a group of 352 healthcare workers, 180 days after the second shot of Pfizer-Biontech mRna vaccine. VisMederi founder and CSO Emanuele...
by VH102021 | Mar 9, 2022 | News&events
VisMederi Textyle, the VisMederi group company dealing with Quality Control on textile materials, becomes the reference centre for the international non-profit association Peta “People for the Ethical Treatment of Animals”. “Our task – CEO Giovanni Micheli says – is...
by VH102021 | Jul 2, 2015 | News&events
An international research team coordinated by the Research Center of Novartis Vaccines and Diagnostics srl (company of GSK Group), has discovered the mechanism that develop narcolepsy after an influenza or an influenza vaccination in subjects genetically predisposed....
